ABSTRACT NUMBER: ESOC2026A184 MINOCYCLINE IMPROVE HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH ACUTE ISCHEAMIC STROKE: RESULTS FROM THE EMPHASIS TRIAL
Qianqian Yang, Ling Guan, Yilong Wang, Luyan Wang, Yao Lu, Meiyang Zhang, Dongyang Zhou · 2026
Read ABSTRACT NUMBER: ESOC2026A184 MINOCYCLINE IMPROVE HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH ACUTE ISCHEAMIC STROKE: RESULTS FROM THE EMPHASIS TRIAL by Qianqian Yang, Ling Guan, Yilong Wang, Luyan Wang, Yao Lu, Meiyang Zhang, Dongyang Zhou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146118.txt.
Description
Qianqian Yang and co-authors report a 2026 conference study on a common drug and quality of life after acute stroke. The drug, minocycline, may guard brain cells, but its effect on how patients rate their own health was untested. The EMPHASIS trial gave the drug or a dummy pill within three days of onset.
More than seventeen hundred patients joined the trial, and near all filled in a health survey at ninety days. Overall health scores did not differ between the drug and dummy groups. Still, a larger share on the drug reached a good health state. Scores for movement, self-care, and daily tasks also favored the drug. The authors stress patient-rated measures in stroke follow-up.
Catalog record
| CREATOR | Qianqian Yang, Ling Guan, Yilong Wang, Luyan Wang, Yao Lu, Meiyang Zhang, Dongyang Zhou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |